Kaori Kuramitsu Selected Research

Kaori Kuramitsu Research Topics

Disease

25	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 11/2011
16	Neoplasms (Cancer) 01/2022 - 06/2007
9	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2011
5	Thrombosis (Thrombus) 01/2022 - 06/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 11/2014
3	Residual Neoplasm 12/2021 - 04/2013
3	Liver Failure 12/2021 - 04/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 07/2013
3	Infections 11/2017 - 01/2013
3	Disease Progression 06/2016 - 11/2014
2	COVID-19 06/2022 - 05/2022
2	Liver Neoplasms (Liver Cancer) 10/2019 - 03/2014
2	Hepatitis C 11/2017 - 06/2016
2	Massive Hepatic Necrosis 10/2015 - 03/2015
1	Inflammation (Inflammations) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 12/2021
1	Sarcopenia 11/2021
1	Acute-On-Chronic Liver Failure 06/2021
1	Cicatrix (Scar) 12/2020
1	End Stage Liver Disease 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2019
1	Cholangitis 10/2019
1	Body Weight (Weight, Body) 10/2019
1	Osteosarcoma (Osteogenic Sarcoma) 11/2016
1	Thrombocytopenia (Thrombopenia) 06/2016
1	Fibrosis (Cirrhosis) 06/2016
1	Hepatorenal Syndrome 06/2016
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2015
1	Persistent Infection 11/2015
1	Lymphoma (Lymphomas) 10/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2015
1	Sinistral Portal Hypertension 11/2014
1	Hemorrhage 11/2014
1	Lymphatic Metastasis 04/2013
1	Hepatitis B 01/2013
1	Necrosis 11/2012
1	Cholangiocarcinoma 11/2011
1	Carcinoma (Carcinomatosis) 11/2011
1	Lung Neoplasms (Lung Cancer) 11/2011
1	Retinoblastoma (Glioblastoma, Retinal) 06/2011

Drug/Important Bio-Agent (IBA)

2	atezolizumabIBA 03/2022 - 12/2021
2	Bevacizumab (Avastin)FDA Link 03/2022 - 12/2021
2	AlbuminsIBA 01/2022 - 04/2020
2	Fetal Proteins (Fetoprotein)IBA 12/2021 - 01/2015
2	lenvatinibIBA 09/2021 - 10/2020
2	BilirubinIBA 06/2021 - 04/2020
2	asunaprevirIBA 11/2017 - 06/2016
2	daclatasvirIBA 11/2017 - 06/2016
2	Pharmaceutical PreparationsIBA 06/2016 - 09/2015
2	RNA (Ribonucleic Acid)IBA 11/2015 - 01/2013
2	Sorafenib (BAY 43-9006)FDA Link 09/2015 - 03/2014
2	Prothrombin (Factor II)IBA 01/2015 - 03/2014
1	SuspensionsIBA 06/2022
1	C-Reactive ProteinIBA 01/2022
1	RamucirumabIBA 09/2021
1	Mitochondrial DNA (mtDNA)IBA 12/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2019
1	Concanavalin AIBA 10/2019
1	Amine Oxidase (Copper-Containing)IBA 10/2019
1	InterferonsIBA 06/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2016
1	AntibodiesIBA 11/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2013
1	pgRNAIBA 01/2013
1	Circular DNAIBA 01/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2013
1	acarboxyprothrombin (PIVKA)IBA 11/2012
1	gadolinium ethoxybenzyl DTPA FDA Link 11/2012
1	CyclinsIBA 06/2011
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2011
1	poliovirus receptorIBA 06/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2007
1	Integrin alphaVbeta3IBA 06/2007

Therapy/Procedure

19	Hepatectomy 01/2022 - 06/2011
9	Liver Transplantation 12/2021 - 03/2015
8	Therapeutics 03/2022 - 11/2011
6	Transplantation 06/2022 - 03/2015
6	Drug Therapy (Chemotherapy) 10/2019 - 11/2011
4	Radiofrequency Ablation 11/2014 - 11/2011
3	Pancreatectomy 01/2022 - 11/2016
2	Kidney Transplantation 06/2022 - 05/2022
2	Pancreaticoduodenectomy 12/2021 - 11/2014
2	Adjuvant Chemotherapy 10/2019 - 11/2014
2	Combined Modality Therapy 10/2019 - 09/2015
2	Contraindications 06/2016 - 10/2015
1	Minimally Invasive Surgical Procedures 01/2022
1	Thrombectomy 09/2017
1	Blood Transfusion (Blood Transfusions) 11/2015
1	Chemoradiotherapy 11/2014
1	Sclerotherapy 11/2014
1	Lymph Node Excision (Lymph Node Dissection) 04/2013
1	Punctures 01/2012
1	Surgical Instruments (Clip) 01/2012
1	Heavy Ion Radiotherapy 11/2011